3-(propan-2-yloxy)propanoic acid | 41255-85-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 3-(propan-2-yloxy)propanoic acid
• 英文别名: 3-Isopropoxy-propionsaeure；3-isopropoxy-propionic acid；3-Isopropyloxy-propionsaeure；2'-propoxypropionic acid；3-(1-methylethoxy)propionic acid；3-propan-2-yloxypropanoic acid
• CAS: 41255-85-0
• 化学式: C₆H₁₂O₃
• mdl: MFCD09931386
• 分子量: 132.159
• InChiKey: DVNBASXKSCNLKQ-UHFFFAOYSA-N

物化性质

• 沸点：
  220-221 °C(Press: 744 Torr)
• 密度：
  1.024±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.833
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(propan-2-yloxy)propanoic acid 生成 3-isopropoxy-propionic acid-(4-bromo-phenacyl ester)
  参考文献：
  名称：

  Christian; Hixon, Journal of the American Chemical Society, 1948, vol. 70, p. 1334

  摘要：

  DOI：
• 作为产物：
  描述：

  3-异丙氧基丙腈 在 硫酸 作用下， 生成 3-(propan-2-yloxy)propanoic acid
  参考文献：
  名称：

  Synthesis of Certain 2-Alkoxyethyl Phenyl Ketones

  摘要：

  DOI：

  10.1021/ja01178a065

文献信息

• METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE
  申请人：Idemitsu Kosan Co., Ltd

  公开号：EP2837619A1

  公开（公告）日：2015-02-18

  A method for producing a β-alkoxypropionamide including reacting a β-alkoxypropionic acid ester represented by the following formula (1) and an amine represented by the following formula (2) in the presence of a polyol and a basic catalyst, thereby to produce a β-alkoxypropionamide represented by the following formula (3), wherein, as the polyol, a reaction residue that is generated by the reaction and contains a used polyol is used: (wherein in the formulas, R and R' are independently a C1 to C6 linear, branched or cyclic, saturated hydrocarbon group; R1 and R2 are independently a C1 to C6 linear, branched or cyclic, saturated hydrocarbon group; and R3 is H or CH3).

  生产β-烷氧基丙酰胺的方法包括在多元醇和碱性催化剂存在下，使以下式（1）所代表的β-烷氧基丙酸酯与以下式（2）所代表的胺发生反应，从而生成以下式（3）所代表的β-烷氧基丙酰胺， 其中作为多元醇，使用由反应生成并含有已使用的多元醇的反应残留物：（在公式中，R和R'分别是C1到C6的直链、支链或环状饱和碳氢基团；R1和R2分别是C1到C6的直链、支链或环状饱和碳氢基团；R3是H或CH3）。
• Composition for Sterilization Comprising W-Alkoxyperoxycarboxylic Acid
  申请人：Kawakami Masayuki

  公开号：US20080009549A1

  公开（公告）日：2008-01-10

  A peroxycarboxylic acid represented by the general formula (I): (wherein R 1 represents a substituted or unsubstituted C1-C10 alkyl group, or a substituted or unsubstituted C6-C10 aryl group, L represents a substituted or unsubstituted C2-C12 divalent linking group, or R 1 and L may combine to form a ring) and a composition comprising said peroxycarboxylic acid are provided. Said peroxycarboxylic acid can sterilize a medical apparatus such as endoscope in a short period of time and has no unpleasant smell.

  通用公式（I）表示的过氧羧酸： （其中R1表示取代或未取代的C1-C10烷基或取代或未取代的C6-C10芳基，L表示取代或未取代的C2-C12双价连接基，或R1和L可以结合形成环）以及包含所述过氧羧酸的组合物。所述过氧羧酸可以在短时间内对医疗器械如内窥镜进行灭菌，并且没有令人不愉快的气味。
• HIV REPLICATION INHIBITOR
  申请人：Shionogi & Co., Ltd.

  公开号：US20140249306A1

  公开（公告）日：2014-09-04

  The present invention provides a novel compound having an antiviral action, in particular, an HIV replication inhibiting action, as well as a pharmaceutical composition, in particular, an anti-HIV agent. wherein, a broken line means the presence or absence of a bond; R 1 is substituted or unsubstituted alkyl etc., R 2 is substituted or unsubstituted alkyloxy etc.; n is 1 or 2; R 3 is a substituted or unsubstituted aromatic carbocyclic group; R 4 is a hydrogen atom etc.; R 5 is a substituted or unsubstituted aromatic carbocyclic group etc.; Y is a single bond etc.; R 6 is substituted or unsubstituted alkyl; R 7 is —Z—R 71 etc.; Z is —NR 72 —CO— etc.; R 71 is substituted or unsubstituted alkyl etc.; R 72 is a hydrogen atom etc.

  本发明提供了一种具有抗病毒作用的新化合物，特别是具有抑制HIV复制作用的化合物，以及一种药物组合物，特别是一种抗HIV药物。其中，虚线表示键的存在或不存在；R1是取代或未取代的烷基等，R2是取代或未取代的烷氧基等；n为1或2；R3是取代或未取代的芳香环烷基；R4是氢原子等；R5是取代或未取代的芳香环烷基等；Y是单键等；R6是取代或未取代的烷基；R7是—Z—R71等；Z是—NR72—CO—等；R71是取代或未取代的烷基等；R72是氢原子等。
• IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS
  申请人：KNOPP BIOSCIENCES LLC

  公开号：US20160031875A1

  公开（公告）日：2016-02-04

  Compounds represented by formula 1 can be potent and/or partially selective for the Kv7.2/7.3 heteromultimer. They may be useful in treating disorders related to seizures, pain, neurotransmitter release, etc.

  由公式1表示的化合物可能对Kv7.2/7.3异源多聚体具有强效和/或部分选择性。它们可能在治疗与癫痫、疼痛、神经递质释放等相关的疾病方面有用。
• [EN] COMPOUNDS AND THERAPEUTIC USES THEREOF<br/>[FR] COMPOSÉS ET LEURS UTILISATIONS THÉRAPEUTIQUES
  申请人：CENTAURI THERAPEUTICS LTD

  公开号：WO2017060729A1

  公开（公告）日：2017-04-13

  The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.

  该发明涉及具有将免疫反应与特定治疗靶标联系起来的新化合物，以及将该类化合物用于治疗癌症、由感染性因子介导和/或引起的疾病或紊乱，包含该类化合物的组合物，其制备过程以及用于该过程的新中间体。